Fezolinetant is a small-molecule, selective neurokinin-3 (NK3) receptor antagonist intended for use as a pharmaceutical raw material. It is primarily supplied for the manufacturing of medications addressing vasomotor symptoms related to menopause.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1629229-37-3
Biafungin acetate
pharmaceutical raw material
Gestrinone
pharmaceutical raw material
Cholane-3,7,24-triol, 6-ethyl-, (3α,5β,6β,7β)-
pharmaceutical raw material
Inecalcitol
pharmaceutical raw material
(4-fluorophenyl)-[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
PPSNFPASKFYPMN-SECBINFHSA-N
C[C@@H]1C2=NN=C(N2CCN1C(=O)C3=CC=C(C=C3)F)C4=NC(=NS4)C